Lv13
66 积分 2025-03-15 加入
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
1小时前
待确认
Alectinib: A Review in Advanced, ALK-Positive NSCLC
1小时前
已完结
Fruquintinib: First Global Approval
1小时前
已完结
<p>Validated UPLC-MS/MS method for quantification of fruquintinib in rat plasma and its application to pharmacokinetic study</p>
1小时前
已完结
Tivozanib: First Global Approval
2天前
已完结
皖公网安备34019202002308
